These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8043043

  • 1. Suppression of dyskinesias in advanced Parkinson's disease. II. Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptoms.
    Bennett JP, Landow ER, Schuh LA.
    Neurology; 1993 Aug; 43(8):1551-5. PubMed ID: 8043043
    [Abstract] [Full Text] [Related]

  • 2. Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction.
    Bennett JP, Landow ER, Dietrich S, Schuh LA.
    Mov Disord; 1994 Jul; 9(4):409-14. PubMed ID: 7969207
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C.
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.
    Durif F, Debilly B, Galitzky M, Morand D, Viallet F, Borg M, Thobois S, Broussolle E, Rascol O.
    Neurology; 2004 Feb 10; 62(3):381-8. PubMed ID: 14872017
    [Abstract] [Full Text] [Related]

  • 12. Sodium valproate in the treatment of levodopa-induced dyskinesia.
    Price PA, Parkes JD, Marsden CD.
    J Neurol Neurosurg Psychiatry; 1978 Aug 10; 41(8):702-6. PubMed ID: 355601
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Zimmerman TR, Sage JI, Lang AE, Mark MH.
    Mov Disord; 1994 Mar 10; 9(2):173-7. PubMed ID: 8196678
    [Abstract] [Full Text] [Related]

  • 20. Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    Turjanski N, Lees AJ.
    J Neurol Neurosurg Psychiatry; 1992 May 10; 55(5):413. PubMed ID: 1602321
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.